“A Randomized, Double-Blind, Placebo-Controlled, Phase 1 2a Trial Protocol to Assess the Safety and Efficacy of TAK-101 Administered by Microneedles in Patients With Celiac Disease”. 2022. Principles and Practice of Clinical Research 8 (3): 37-48. https://doi.org/10.21801/ppcrj.2022.83.5.